Metabolism of prostacyclin in blood vessels.
The activity of 15-hydroxyprostaglandin dehydrogenase has been shown to be high in both mesenteric arteries and veins; the present study suggests that it may be responsible for the inactivation of prostacyclin (PGI2). The cytoplasmic fractions of bovine mesenteric arteries and veins were incubated with radiolabeled PGI2 in the presence of NAD+ or NADP+. The substrate was rapidly converted to a product, which was isolated and identified as 6,15-diketo prostaglandin F1alpha, (6,15-diketo-PGF1alpha) by thin layer chromatography and gas chromatography-mass spectrometry. The initial reaction rate began to level off after less than 1 min of incubation at 37 degrees C. When radiolabeled 6-keto-PGF1alpha, the stable hydrolysis product of PGI2, was used as substrate under the same conditions, 97% was recovered unmetabolized after 2 min of incubation. Catabolism of PGI2 may be a major determinant of its levels in blood vessels and, therefore, may be of crucial importance to regulating the action of PGI2. Further, estimation of PGI2 generation by either tissues or organs may be misleading if only 6-keto-PGF1alpha is measured.
D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives; D000818:Animals; D001158:Arteries / Q000378:metabolism*; D002417:Cattle; D011464:Epoprostenol / Q000378:metabolism*; D006911:Hydroxyprostaglandin Dehydrogenases / Q000378:metabolism*; D007700:Kinetics; D013058:Mass Spectrometry; D009243:NAD; D009249:NADP; D011453:Prostaglandins / Q000378:metabolism*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology; D014680:Veins / Q000378:metabolism*
C017239:6,15-diketoprostaglandin F1alpha; D011453:Prostaglandins; D011461:Prostaglandins F, Synthetic; D009243:NAD; D009249:NADP; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol; D006911:Hydroxyprostaglandin Dehydrogenases